Septodont S0530 RTR+ 80/20 Bone Regeneration Material 0.5cc Syringe

Imported from USA | Ships in 10 working days

5% instant discount on non COD

1

₹ 25000/-

The price at cart2india.com is inclusive of custom duties, GST, freight forwarding and other charges.

Free Shipping across India. Powered by BlueDart

Product Information


Specification
Brand : Septodont
BulletPoint1 : 0.5cc Syringe
BulletPoint2 : 80% B-Tricalcium Phosphate
BulletPoint3 : 20% Hydroxyapatite
BulletPoint4 : Product Quality: The instrument conforms to CE quality mark and ISO standards.
BulletPoint5 : Packaging: Dental apparatus are checked at every stage of production abd carefully packaged.
ExternallyAssignedProductIdentifier1 : 0814645013239
ExternallyAssignedProductIdentifier2 : 814645013239
FdaDeviceClassification : iv
FdaIndicationOfUse : rx
FdaInstructionsForUseType : professional
FdaLabelType : rx_only
FdaPremarketApprovalNumber510k : EXEMPT
FdaPremarketApprovalNumberPma : EXEMPT
IsExpirationDatedProduct : 1
ItemName : Septodont S0530 RTR+ 80/20 Bone Regeneration Material 0.5cc Syringe
ItemPackageDimensions_Height : 1 inches
ItemPackageDimensions_Length : 1 inches
ItemPackageDimensions_Width : 1 inches
ItemPackageQuantity : 2
ItemTypeKeyword : professional-dental-oral-dispensing-syringes
Manufacturer : Septodont
ModelNumber : CRX-BCSAWS
NumberOfBoxes : 1
NumberOfItems : 1
PartNumber : S0530
ProductDescription : RTR+ 80/20 Biphasic Bone Grafting Material, 0.5cc Syringe. The material composition is 80% B-Tricalcium Phosphate and 20% Hydroxyapatite.
ProductExpirationType : Expiration Date Required
ProductSiteLaunchDate : 2024-06-19T18:39:50.194Z
StreetDate : 2018-07-06T00:00:01Z
SupplierDeclaredDgHzRegulation : not_applicable
SupplierDeclaredDgHzRegulation1 : not_applicable
SupplierDeclaredDgHzRegulation2 : not_applicable
UnitCount : 1
UnspscCode : 42000000

Questions & Answers

Have a question? Ask experts

?
No question found

Ratings & Review

Rating Breakdown (average)

5*
0
4*
0
3*
0
2*
0
1*
0

No reviews found.

Have an opinion on this page? Let's hear it.